MediciNova (MNOV) Proxy filing summary

Executive summary

• The annual meeting is scheduled for June 23, 2026, with voting available online, by phone, mail, or in person for shareholders of record as of April 24, 2026.

• Proxy materials and the 2025 Annual Report are primarily distributed via the Internet, with paper copies available upon request.

• The Board recommends voting in favor of all proposals, including director elections, auditor ratification, share authorization increase, and potential adjournment.

Voting matters and shareholder proposals

• Shareholders will vote on electing two Class I directors, ratifying BDO USA, P.C. as auditor, amending the certificate of incorporation to increase authorized common shares from 100,000,000 to 247,000,000, and potentially adjourning the meeting to solicit more votes.

• Shareholder proposals for the 2027 meeting must be submitted by December 30, 2026, for inclusion in proxy materials.

Board of directors and corporate governance

• The Board consists of five members divided into three classes with staggered terms; three directors are independent per Nasdaq standards.

• The Nominating and Corporate Governance Committee emphasizes diversity, experience, and independence in director selection.

• Board committees include Audit, Compensation, and Nominating and Corporate Governance, each chaired by an independent director.